From Menopause to Neurodegeneration-Molecular Basis and Potential Therapy

Area of Science:

• Neurobiology
• Endocrinology
• Gerontology

Background:

• Menopause involves declining estrogen and progesterone, affecting brain function.
• Neurodegenerative diseases, like Alzheimer's disease (AD), show higher incidence in women.
• Steroid hormones and Insulin-like Growth Factor 1 (IGF-1) play crucial neuroprotective roles.

Purpose of the Study:

• To review the roles of estrogen, progesterone, and IGF-1 in the aging brain.
• To explore the link between menopausal hormone changes and neurodegenerative diseases, particularly AD.
• To analyze the therapeutic potential and controversies surrounding hormone replacement therapy (HRT) for neurodegenerative conditions.

Main Methods:

• Review of existing literature on steroid hormones, IGF-1, and neuroprotection.
• Analysis of signaling pathways affected by aging and hormone changes.
• Examination of molecular mechanisms, including estrogen's effect on N-methyl-d-aspartic acid receptors (NMDARs).

Main Results:

• Estrogen, progesterone, and IGF-1 signaling pathways are altered with aging and menopause.
• These hormonal changes are associated with increased risk and progression of neurodegenerative diseases in women.
• Hormone therapy's effectiveness is complex due to intricate signaling and aging effects.

Conclusions:

• Hormone therapy may not reverse established Alzheimer's disease but could potentially treat earlier stages like mild cognitive impairment.
• Understanding complex hormonal signaling is key to resolving HRT's controversial role in neuroprotection.
• Further research into specific pathways may clarify therapeutic strategies for menopausal women at risk of cognitive decline.